Insider · CIK 0001720907
Stephanie Monaghan O'Brien
Files at APLS (Apellis Pharmaceuticals, Inc.). First filing -, latest -.
Stephanie Monaghan O'Brien files SEC Form 4 as director at APLS (Apellis Pharmaceuticals, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Stephanie Monaghan O'Brien has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 21 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc. | UTender of shares Common Stock | -25,666 | - | - | 0 | May 14, 2026 |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc. | UTender of shares Common Stockindirect: By Spouse | -5,750 | - | - | 0 | May 14, 2026 |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc. | DDisposition to issuer Common Stock | -3,062 | - | - | 0 | May 14, 2026 |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc. | DDisposition to issuer Common Stock | -5,744 | - | - | 0 | May 14, 2026 |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc. | DDisposition to issuer Common Stock | -7,961 | - | - | 0 | May 14, 2026 |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc. | DDisposition to issuer Common Stock | -3,877 | - | - | 0 | May 14, 2026 |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc. | DDisposition to issuer Common Stock | -3,544 | - | - | 0 | May 14, 2026 |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc. | DDisposition to issuer Stock Option (right to buy)derivative | -17,580 | - | - | 0 | May 14, 2026 |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc. | DDisposition to issuer Stock Option (right to buy)derivative | -121,894 | - | - | 0 | May 14, 2026 |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc. | DDisposition to issuer Stock Option (right to buy)derivative | -14,684 | - | - | 0 | May 14, 2026 |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc. | DDisposition to issuer Stock Option (right to buy)derivative | -27,600 | - | - | 0 | May 14, 2026 |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc. | DDisposition to issuer Stock Option (right to buy)derivative | -11,199 | - | - | 0 | May 14, 2026 |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc. | DDisposition to issuer Stock Option (right to buy)derivative | -8,554 | - | - | 0 | May 14, 2026 |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc. | DDisposition to issuer Stock Option (right to buy)derivative | -7,441 | - | - | 0 | May 14, 2026 |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc. | DDisposition to issuer Stock Option (right to buy)derivative | -27,600 | - | - | 0 | May 14, 2026 |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc. | DDisposition to issuer Stock Option (right to buy)derivative | -5,748 | - | - | 0 | May 14, 2026 |
| Apr 6, 2026 | APLS Apellis Pharmaceuticals, Inc. | JOther Common Stockindirect: By Spouse | +5,750 | $0.00 | $0 | 5,750 | Apr 8, 2026 |
| Jan 1, 2026 | APLS Apellis Pharmaceuticals, Inc. | AGrant or award Common Stock | +7,961 | $0.00 | $0 | 25,666 | Jan 5, 2026 |
| Jan 1, 2026 | APLS Apellis Pharmaceuticals, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +14,684 | $0.00 | $0 | 14,684 | Jan 5, 2026 |
| Jan 1, 2025 | APLS Apellis Pharmaceuticals, Inc. | AGrant or award Common Stock | +6,267 | $0.00 | $0 | 17,705 | Jan 3, 2025 |
| Jan 1, 2025 | APLS Apellis Pharmaceuticals, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +11,199 | $0.00 | $0 | 11,199 | Jan 3, 2025 |
Questions about Stephanie Monaghan O'Brien
Answered from the filings on this page, as of the latest one.
Is Stephanie Monaghan O'Brien buying or selling?
Stephanie Monaghan O'Brien has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Stephanie Monaghan O'Brien's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Stephanie Monaghan O'Brien has 0.
Where does Stephanie Monaghan O'Brien file Form 4?
Stephanie Monaghan O'Brien has filed Form 4 at APLS (Apellis Pharmaceuticals, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.